The Bococizumab Biosimilar Anti-PCSK9 Antibody offered by Assay Genie is a cutting-edge research tool designed for studying the PCSK9 pathway, a key player in cholesterol regulation. This antibody, developed as a biosimilar to the original drug bococizumab, is highly specific and sensitive for detecting PCSK9 protein in human samples. It is validated for use in various applications, including ELISA and immunohistochemistry, providing researchers with a reliable tool for investigating the role of PCSK9 in cardiovascular health and disease.
PCSK9, a proprotein convertase subtilisin/kexin type 9, has emerged as a promising target for lowering LDL cholesterol levels and reducing the risk of cardiovascular events. Inhibiting PCSK9 function has shown to be effective in treating hypercholesterolemia and preventing atherosclerosis. By using the Bococizumab Biosimilar Anti-PCSK9 Antibody, researchers can gain insights into the mechanisms of PCSK9 regulation and explore potential therapeutic strategies for managing dyslipidemia and cardiovascular disorders.
Product Name:
Bococizumab (Anti-PCSK9) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0109
Target:
PCSK9
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
PF-04950615, RN-316, RN316
Description:
Anti-PCSK9(bococizumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG2
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
